Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director

InMed Pharmaceuticals Inc. (INM) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/16/2023 4 HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 152 options to buy @ $0
05/16/2023 4 MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 485 options to buy @ $0
05/16/2023 4 ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 1,818 options to buy @ $0
03/09/2023 4 MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 61 options to buy @ $0
03/09/2023 4 HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 545 options to buy @ $0
03/09/2023 4 ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 545 options to buy @ $0
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Grove Janet P (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Granted 840 options to buy @ $1.78, valued at $1.5k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
11/29/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
11/18/2022 4/A Johnson Shane Aaron (Sr VP & General Manager) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Disposed/sold 4,200 options to buy @ $2.78, valued at $11.7k
11/18/2022 4/A MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Disposed/sold 4,200 options to buy @ $2.78, valued at $11.7k
11/18/2022 4/A HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Disposed/sold 4,200 options to buy @ $2.78, valued at $11.7k
11/18/2022 4/A ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Disposed/sold 15,000 options to buy @ $2.78, valued at $41.7k
11/18/2022 4/A WOUDENBERG MICHAEL (COO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Disposed/sold 7,500 options to buy @ $2.78, valued at $20.9k
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/02/2022 4 MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 1,515 options to buy @ $0
06/02/2022 4 ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Unknown transaction of 13,636 options to buy @ $0
05/19/2022 4 Baldasare Bryan T (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns: Granted 14,000 options to buy @ $0.8, valued at $11.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy